Merida Biosciences Funding: $121M Raised, Series A (2025)
Merida Biosciences is a Biotech company based in Cambridge, Massachusetts. It has raised $121M in total funding. Latest round: Series A.
Merida Biosciences funding overview
Merida Biosciences is a Biotech company based in Cambridge, Massachusetts. Merida Biosciences has raised $121M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2025. The round record for Merida Biosciences runs through 2025; nothing later has been disclosed. Investors on record include Bain Capital Life Sciences, BVF Partners, Third Rock Ventures. 3 distinct backers are named across the disclosed rounds.
Merida Biosciences at a glance
Total raised
$121M
Latest round
Series A
Latest round date
April 2025
Industry
Biotech
Headquarters
Cambridge, Massachusetts
Notable investors
Bain Capital Life Sciences, BVF Partners, Third Rock Ventures
Frequently asked about Merida Biosciences funding
How much has Merida Biosciences raised?
Merida Biosciences has raised $121M in total disclosed funding across the rounds on record.
Who has invested in Merida Biosciences?
Bain Capital Life Sciences, BVF Partners, Third Rock Ventures are named among the investors backing Merida Biosciences.
What was the latest Merida Biosciences funding round?
The most recent disclosed round is a Series A, announced in April 2025.
Where is Merida Biosciences based?
Merida Biosciences is based in Cambridge, Massachusetts.
What sector does Merida Biosciences operate in?
Merida Biosciences is tracked under Biotech from Cambridge, Massachusetts, with $121M in disclosed funding.
When did Merida Biosciences last raise?
The last disclosed Merida Biosciences round closed in April 2025 at Series A.
Round data for Merida Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Cambridge and backer lists below.
